Craft

Advanced
Myonexus

Myonexus

Myonexus Summary

Company Summary

Overview
Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing treatments for Limb-girdle muscular dystrophy Types 2D, 2B, 2E, 2L, and 2C. 
Type
Subsidiary
Status
Closed
Founded
2017
HQ
Columbus, OH, US | view all locations
Website
http://www.myonexustx.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Michael Triplett

    Michael Triplett, President & Chief Executive Officer

    • Bruce Halpryn

      Bruce Halpryn, Secretary & Chief Operating Officer

      • Louise Rodino-Klapac

        Louise Rodino-Klapac, Chief Scientific Officer

        • Peter Kleinhenz

          Peter Kleinhenz, Treasurer & Chief Financial Officer

          LocationsView all

          1 location detected

          • Columbus, OH HQ

            United States

            Columbus, OH, USA

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX